Avatrombopag vs. Placebo for CIT in GI Malignancies

Clinical trial NCT05772546 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05772546
Sponsor: Hanny Al-Samkari, MD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Cancer Gastrointestinal Neoplasms Chemotherapy-Induced Thrombocytopenia

Start date: 2023-11-01
Primary completion: 2026-01-02
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.